Expand ENSC Menu
ENSC MENU

ENSC Latest Press Releases

-- January 28, 2026 --

Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain ACCESS Newswire 8:00 AM

-- January 21, 2026 --

Ensysce Biosciences Expands Global Opioid Patent Portfolio ACCESS Newswire 8:00 AM

-- January 5, 2026 --

Ensysce Biosciences Issues Annual Shareholder Letter ACCESS Newswire 8:00 AM

-- December 12, 2025 --

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC) Globe Newswire 8:00 AM

-- December 9, 2025 --

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid ACCESS Newswire 8:00 AM

-- December 2, 2025 --

Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology ACCESS Newswire 8:00 AM

-- November 20, 2025 --

Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach ACCESS Newswire 8:00 AM

-- November 17, 2025 --

Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs ACCESS Newswire 8:05 AM
Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC) Globe Newswire 8:00 AM

-- November 14, 2025 --

Ensysce Biosciences Reports Third Quarter 2025 Financial Results ACCESS Newswire 4:15 PM

-- October 10, 2025 --

Ensysce Biosciences Releases Symposium Highlights from PAINWeek 2025 ACCESS Newswire 8:00 AM
Market Data Delayed 15 Minutes